Literature DB >> 16892407

Anophthalmia-esophageal atresia syndrome caused by an SOX2 gene deletion in monozygotic twin brothers with markedly discordant phenotypes.

Juan Carlos Zenteno1, Hector J Perez-Cano, Monica Aguinaga.   

Abstract

The clinical combination of anophthalmia/microphthalmia and esophageal atresia was first recognized in 1988 as a distinct variable multi-system malformation syndrome and since then at least 17 cases of the disease have been described, all of them sporadic in occurrence. We report a heterozygous SOX2 gene mutation underlying the syndrome of anophthalmia/microphthalmia-esophageal atresia and demonstrate that this entity can be associated to considerable clinical variability as shown by the discordant ocular phenotype observed in monozygotic twin brothers carrying an SOX2 deletion. This is the first report describing a strikingly discordant eye phenotype in monozygotic twins with the condition, with one of our patients being the first reported individual carrying an SOX2 lesion associated with unilateral eye defect. We discuss the probable sources for this remarkable phenotypic heterogeneity of the anophthalmia/microphthalmia syndrome in individuals with an identical genetic constitution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16892407     DOI: 10.1002/ajmg.a.31384

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

Review 1.  Eye development genes and known syndromes.

Authors:  Anne M Slavotinek
Journal:  Mol Genet Metab       Date:  2011-09-29       Impact factor: 4.797

2.  Combinatorial regulation of optic cup progenitor cell fate by SOX2 and PAX6.

Authors:  Danielle Matsushima; Whitney Heavner; Larysa H Pevny
Journal:  Development       Date:  2011-02       Impact factor: 6.868

Review 3.  Genetics of syndromic ocular coloboma: CHARGE and COACH syndromes.

Authors:  Aman George; Tiziana Cogliati; Brian P Brooks
Journal:  Exp Eye Res       Date:  2020-02-04       Impact factor: 3.467

4.  Examination of SOX2 in variable ocular conditions identifies a recurrent deletion in microphthalmia and lack of mutations in other phenotypes.

Authors:  Linda M Reis; Rebecca C Tyler; Adele Schneider; Tanya Bardakjian; Elena V Semina
Journal:  Mol Vis       Date:  2010-04-28       Impact factor: 2.367

5.  Novel SOX2 mutations and genotype-phenotype correlation in anophthalmia and microphthalmia.

Authors:  Adele Schneider; Tanya Bardakjian; Linda M Reis; Rebecca C Tyler; Elena V Semina
Journal:  Am J Med Genet A       Date:  2009-12       Impact factor: 2.802

6.  Esophageal atresia with tracheoesophageal fistula in both members of monozygotic twins.

Authors:  Koichi Ohno; Tetsuro Nakamura; Takashi Azuma; Tatsuyuki Yoshida; Hiroto Yamada; Hiroaki Hayashi; Kazunori Masahata
Journal:  Pediatr Surg Int       Date:  2008-10       Impact factor: 1.827

7.  Novel SOX2 partner-factor domain mutation in a four-generation family.

Authors:  Marija Mihelec; Peter Abraham; Kate Gibson; Renata Krowka; Rachel Susman; Rebecca Storen; Yongjuan Chen; Jenny Donald; Patrick P L Tam; John R Grigg; Maree Flaherty; Glen A Gole; Robyn V Jamieson
Journal:  Eur J Hum Genet       Date:  2009-05-27       Impact factor: 4.246

8.  Familial recurrence of SOX2 anophthalmia syndrome: phenotypically normal mother with two affected daughters.

Authors:  Adele Schneider; Tanya M Bardakjian; Jie Zhou; Nkecha Hughes; Rosanne Keep; Darnelle Dorsainville; Femida Kherani; James Katowitz; Lisa A Schimmenti; Marybeth Hummel; David R Fitzpatrick; Terri L Young
Journal:  Am J Med Genet A       Date:  2008-11-01       Impact factor: 2.802

9.  Cleft Palate in a Mouse Model of SOX2 Haploinsufficiency.

Authors:  Lee Langer; Kathleen Sulik; Larysa Pevny
Journal:  Cleft Palate Craniofac J       Date:  2013-05-02

10.  SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions.

Authors:  P Bakrania; D O Robinson; D J Bunyan; A Salt; A Martin; J A Crolla; A Wyatt; A Fielder; J Ainsworth; A Moore; S Read; J Uddin; D Laws; D Pascuel-Salcedo; C Ayuso; L Allen; J R O Collin; N K Ragge
Journal:  Br J Ophthalmol       Date:  2007-05-23       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.